Difference between revisions of "Chaudhry P, et al. Blood (2017) cited as Ref 219 in DOI: 10.1038/s41392-020-0110-5 (Q9482)"
Jump to navigation
Jump to search
(Created claim: Fourth Author string (P152): Guzman M, #quickstatements; #temporary_batch_1590155310798) |
(Created claim: Fifth Author string (P153): Merchant AA, #quickstatements; #temporary_batch_1590155508986) |
||
| Property / Fifth Author string | |||
| + | Merchant AA | ||
| Property / Fifth Author string: Merchant AA / rank | |||
| + | Normal rank | ||
Latest revision as of 13:52, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Chaudhry P, et al. Blood (2017) cited as Ref 219 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Chaudhry P
0 references
Singh M
0 references
Triche TJ
0 references
2017
0 references
Blood
0 references
129
0 references
GLI3 repressor determines Hedgehog pathway activation and is required for response to SMO antagonist glasdegib in AML (English)
0 references
3465-3475
0 references
Guzman M
0 references
Merchant AA
0 references
